Literature DB >> 35819686

Predictive Efficiency of Prediabetes for Diabetes Among Chinese Middle-Aged and Older Populations: a 5-Year National Prospective Cohort Study.

Hang Sun1,2,3, Lu Xu4, Lili Liu5, Siyan Zhan6,7,8, Shengfeng Wang9, Yongfeng Song10,11,12.   

Abstract

BACKGROUND: Limited studies have explored the predictive efficiency of prediabetes based on two definitions for diabetes among Chinese middle-aged and older populations with prediabetes.
OBJECTIVE: To evaluate the predictive efficiency of prediabetes based on two definitions for diabetes and the clinical and public health benefit in Chinese middle-aged and older populations.
DESIGN: A 5-year cohort study from the China Health and Retirement Longitudinal Study. PARTICIPANTS: A total of 5208 participants who had blood sample data at baseline in 2011. MAIN MEASURES: The exposure was prediabetes based on American Diabetes Association (ADA) and World Health Organization (WHO) definition. The main outcome was incident diabetes. The ability of prediabetes for predicting diabetes was assessed by sensitivity, specificity, positive predictive value, and negative predictive value. Cox proportional hazards regression was used to explore the associations between prediabetes and the 5-year risk of diabetes and all-cause mortality. KEY
RESULTS: Among those with prediabetes according to the ADA definition, only 426 (15.45%) with baseline prediabetes progressed to total diabetes, while according to the WHO definition, 208 (21.89%) progressed to total diabetes. In terms of the ability of predicting the incident total diabetes in 5 years, the ADA definition has a higher sensitivity than the WHO definition (70.76% versus 34.55%, P < 0.001), while the WHO definition has a higher specificity than the ADA definition (84.09% versus 49.35%, P < 0.001). Positive predictive values based on the two definitions were low (< 24%); negative predictive values were high (> 90%).
CONCLUSIONS: Neither definition of prediabetes is robust for predicting diabetes development in Chineses middle-aged and older populations.
© 2022. The Author(s), under exclusive licence to Society of General Internal Medicine.

Entities:  

Keywords:  Aging; Chinese population; Diagnostic criteria; Prediabetes; Type 2 diabetes

Year:  2022        PMID: 35819686     DOI: 10.1007/s11606-022-07731-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   6.473


  28 in total

Review 1.  Impaired fasting glucose and impaired glucose tolerance: implications for care.

Authors:  David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

2.  Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.

Authors:  N G Forouhi; J Luan; S Hennings; N J Wareham
Journal:  Diabet Med       Date:  2007-02       Impact factor: 4.359

3.  Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).

Authors:  Yaohui Zhao; Yisong Hu; James P Smith; John Strauss; Gonghuan Yang
Journal:  Int J Epidemiol       Date:  2012-12-12       Impact factor: 7.196

4.  Prevalence and control of diabetes in Chinese adults.

Authors:  Yu Xu; Limin Wang; Jiang He; Yufang Bi; Mian Li; Tiange Wang; Linhong Wang; Yong Jiang; Meng Dai; Jieli Lu; Min Xu; Yichong Li; Nan Hu; Jianhong Li; Shengquan Mi; Chung-Shiuan Chen; Guangwei Li; Yiming Mu; Jiajun Zhao; Lingzhi Kong; Jialun Chen; Shenghan Lai; Weiqing Wang; Wenhua Zhao; Guang Ning
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

5.  Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.

Authors:  Mohammed K Ali; Kai McKeever Bullard; Sharon Saydah; Giuseppina Imperatore; Edward W Gregg
Journal:  Lancet Diabetes Endocrinol       Date:  2018-02-27       Impact factor: 32.069

Review 6.  Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.

Authors:  Cheng Hu; Weiping Jia
Journal:  Diabetes       Date:  2018-01       Impact factor: 9.461

7.  Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes.

Authors:  Z S Chi; E T Lee; M Lu; H Keen; P H Bennett
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

Review 8.  Introduction to diabetes mellitus.

Authors:  Kirti Kaul; Joanna M Tarr; Shamim I Ahmad; Eva M Kohner; Rakesh Chibber
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

9.  Risk of Progression to Diabetes Among Older Adults With Prediabetes.

Authors:  Mary R Rooney; Andreea M Rawlings; James S Pankow; Justin B Echouffo Tcheugui; Josef Coresh; A Richey Sharrett; Elizabeth Selvin
Journal:  JAMA Intern Med       Date:  2021-04-01       Impact factor: 21.873

10.  The Prevalence of Diabetes and Prediabetes in the Adult Population of Jeddah, Saudi Arabia--A Community-Based Survey.

Authors:  Suhad M Bahijri; Hanan A Jambi; Rajaa M Al Raddadi; Gordon Ferns; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.